back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2017-02-01 Tx date 2017-01-27 |
$VANC
Vanc Pharmaceuticals Inc. |
NAYYAR, ARUN
5 - Senior Officer of Issuer
Holder: Arun Nayyar Inc. (Indirect Ownership)
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
-437,500 vol |
0 | |
| Filed 2016-11-25 Tx date 2016-11-21 |
$VANC
Vanc Pharmaceuticals Inc. |
NAYYAR, ARUN
5 - Senior Officer of Issuer
Holder: Arun Nayyar Inc. (Indirect Ownership)
|
Common Shares
37 - Stock split or consolidation
|
-900,000 vol |
300,000 | |
| Filed 2016-11-25 Tx date 2016-11-21 |
$VANC
Vanc Pharmaceuticals Inc. |
NAYYAR, ARUN
5 - Senior Officer of Issuer
Holder: Arun Nayyar Inc. (Indirect Ownership)
|
Options
37 - Stock split or consolidation
|
-1,312,500 vol |
437,500 | |
| Filed 2016-01-29 Tx date 2016-01-27 |
$NPH
Vanc Pharmaceuticals Inc. |
NAYYAR, ARUN
5 - Senior Officer of Issuer
Holder: Arun Nayyar Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-12,047.50
-30,500 vol $0.395 each |
1,420,500 | |
| Filed 2016-01-29 Tx date 2016-01-27 |
$NPH
Vanc Pharmaceuticals Inc. |
NAYYAR, ARUN
5 - Senior Officer of Issuer
Holder: Arun Nayyar Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-8,970
-23,000 vol $0.39 each |
1,451,000 | |
| Filed 2016-01-29 Tx date 2016-01-26 |
$NPH
Vanc Pharmaceuticals Inc. |
NAYYAR, ARUN
5 - Senior Officer of Issuer
Holder: Arun Nayyar Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,620
-4,000 vol $0.405 each |
1,496,000 | |
| Filed 2016-01-29 Tx date 2016-01-27 |
$NPH
Vanc Pharmaceuticals Inc. |
NAYYAR, ARUN
5 - Senior Officer of Issuer
Holder: Arun Nayyar Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-8,470
-22,000 vol $0.385 each |
1,474,000 | |
| Filed 2016-01-29 Tx date 2016-01-27 |
$NPH
Vanc Pharmaceuticals Inc. |
NAYYAR, ARUN
5 - Senior Officer of Issuer
Holder: Arun Nayyar Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-405.00
-1,000 vol $0.405 each |
1,400,000 | |
| Filed 2016-01-29 Tx date 2016-01-27 |
$NPH
Vanc Pharmaceuticals Inc. |
NAYYAR, ARUN
5 - Senior Officer of Issuer
Holder: Arun Nayyar Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-7,800
-19,500 vol $0.40 each |
1,401,000 | |
| Filed 2016-01-22 Tx date 2016-01-20 |
$NPH
Vanc Pharmaceuticals Inc. |
NAYYAR, ARUN
5 - Senior Officer of Issuer
Holder: Arun Nayyar Inc. (Indirect Ownership)
|
Common Shares
51 - Exercise of options
|
$20,000
+200,000 vol $0.10 each |
1,500,000 | |
| Filed 2016-01-22 Tx date 2016-01-20 |
$NPH
Vanc Pharmaceuticals Inc. |
NAYYAR, ARUN
5 - Senior Officer of Issuer
Holder: Arun Nayyar Inc. (Indirect Ownership)
|
Options
50 - Grant of options
|
$210,000
+600,000 vol $0.35 each |
1,750,000 | |
| Filed 2016-01-22 Tx date 2016-01-20 |
$NPH
Vanc Pharmaceuticals Inc. |
NAYYAR, ARUN
5 - Senior Officer of Issuer
Holder: Arun Nayyar Inc. (Indirect Ownership)
|
Options
51 - Exercise of options
|
$-20,000
-200,000 vol $0.10 each |
1,150,000 | |
| Filed 2016-01-22 Tx date 2016-01-20 |
$NPH
Vanc Pharmaceuticals Inc. |
NAYYAR, ARUN
5 - Senior Officer of Issuer
Holder: Arun Nayyar Inc. (Indirect Ownership)
|
Options
51 - Exercise of options
|
$-100,000
-1,000,000 vol $0.10 each |
1,350,000 | |
| Filed 2016-01-22 Tx date 2016-01-20 |
$NPH
Vanc Pharmaceuticals Inc. |
NAYYAR, ARUN
5 - Senior Officer of Issuer
Holder: Arun Nayyar Inc. (Indirect Ownership)
|
Common Shares
51 - Exercise of options
|
$100,000
+1,000,000 vol $0.10 each |
1,300,000 | |
| Filed 2016-01-05 Tx date 2016-01-04 |
$NPH
Vanc Pharmaceuticals Inc. |
NAYYAR, ARUN
5 - Senior Officer of Issuer
Holder: Arun Nayyar Inc. (Indirect Ownership)
|
Common Shares
54 - Exercise of warrants
|
$39,000
+300,000 vol $0.13 each |
300,000 | |
| Filed 2016-01-05 Tx date 2013-11-25 |
$NPH
Vanc Pharmaceuticals Inc. |
NAYYAR, ARUN
5 - Senior Officer of Issuer
Holder: Arun Nayyar Inc. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-01-05 Tx date 2016-01-04 |
$NPH
Vanc Pharmaceuticals Inc. |
NAYYAR, ARUN
5 - Senior Officer of Issuer
Holder: Arun Nayyar Inc. (Indirect Ownership)
|
Warrants
54 - Exercise of warrants
|
$-39,000
-300,000 vol $0.13 each |
0 | |
| Filed 2015-11-24 Tx date 2013-11-25 |
$NPH
Vanc Pharmaceuticals Inc. |
NAYYAR, ARUN
5 - Senior Officer of Issuer
Holder: Arun Nayyar Inc. (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-11-24 Tx date 2015-11-24 |
$NPH
Vanc Pharmaceuticals Inc. |
NAYYAR, ARUN
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
90 - Change in the nature of ownership
|
$-39,000
-300,000 vol $0.13 each |
0 | |
| Filed 2015-11-24 Tx date 2015-11-24 |
$NPH
Vanc Pharmaceuticals Inc. |
NAYYAR, ARUN
5 - Senior Officer of Issuer
Holder: Arun Nayyar Inc. (Indirect Ownership)
|
Warrants
90 - Change in the nature of ownership
|
$39,000
+300,000 vol $0.13 each |
300,000 | |
| Filed 2015-10-23 Tx date 2015-10-19 |
$NPH
Vanc Pharmaceuticals Inc. |
NAYYAR, ARUN
5 - Senior Officer of Issuer
Holder: Arun Nayyar Inc. (Indirect Ownership)
|
Options
90 - Change in the nature of ownership
|
$22,500
+150,000 vol $0.15 each |
1,350,000 | |
| Filed 2015-10-23 Tx date 2015-10-19 |
$NPH
Vanc Pharmaceuticals Inc. |
NAYYAR, ARUN
5 - Senior Officer of Issuer
Holder: Arun Nayyar Inc. (Indirect Ownership)
|
Options
90 - Change in the nature of ownership
|
$20,000
+200,000 vol $0.10 each |
1,200,000 | |
| Filed 2015-10-23 Tx date 2015-10-19 |
$NPH
Vanc Pharmaceuticals Inc. |
NAYYAR, ARUN
5 - Senior Officer of Issuer
Holder: Arun Nayyar Inc. (Indirect Ownership)
|
Options
90 - Change in the nature of ownership
|
$100,000
+1,000,000 vol $0.10 each |
1,000,000 | |
| Filed 2015-10-23 Tx date 2013-11-25 |
$NPH
Vanc Pharmaceuticals Inc. |
NAYYAR, ARUN
5 - Senior Officer of Issuer
Holder: Arun Nayyar Inc. (Indirect Ownership)
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-10-23 Tx date 2015-10-19 |
$NPH
Vanc Pharmaceuticals Inc. |
NAYYAR, ARUN
5 - Senior Officer of Issuer
Direct Ownership
|
Options
90 - Change in the nature of ownership
|
$-275,000
-500,000 vol $0.55 each |
0 | |
| Filed 2015-10-23 Tx date 2015-10-19 |
$NPH
Vanc Pharmaceuticals Inc. |
NAYYAR, ARUN
5 - Senior Officer of Issuer
Direct Ownership
|
Options
90 - Change in the nature of ownership
|
$-100,000
-500,000 vol $0.20 each |
500,000 | |
| Filed 2015-10-23 Tx date 2015-10-19 |
$NPH
Vanc Pharmaceuticals Inc. |
NAYYAR, ARUN
5 - Senior Officer of Issuer
Direct Ownership
|
Options
90 - Change in the nature of ownership
|
$-22,500
-150,000 vol $0.15 each |
1,000,000 | |
| Filed 2015-10-23 Tx date 2015-10-19 |
$NPH
Vanc Pharmaceuticals Inc. |
NAYYAR, ARUN
5 - Senior Officer of Issuer
Direct Ownership
|
Options
90 - Change in the nature of ownership
|
$-20,000
-200,000 vol $0.10 each |
1,150,000 | |
| Filed 2015-10-23 Tx date 2015-10-19 |
$NPH
Vanc Pharmaceuticals Inc. |
NAYYAR, ARUN
5 - Senior Officer of Issuer
Direct Ownership
|
Options
90 - Change in the nature of ownership
|
$-100,000
-1,000,000 vol $0.10 each |
1,350,000 | |
| Filed 2015-10-23 Tx date 2015-10-19 |
$NPH
Vanc Pharmaceuticals Inc. |
NAYYAR, ARUN
5 - Senior Officer of Issuer
Holder: Arun Nayyar Inc. (Indirect Ownership)
|
Options
90 - Change in the nature of ownership
|
$275,000
+500,000 vol $0.55 each |
2,350,000 | |
| Filed 2015-10-23 Tx date 2015-10-19 |
$NPH
Vanc Pharmaceuticals Inc. |
NAYYAR, ARUN
5 - Senior Officer of Issuer
Holder: Arun Nayyar Inc. (Indirect Ownership)
|
Options
90 - Change in the nature of ownership
|
$100,000
+500,000 vol $0.20 each |
1,850,000 | |
| Filed 2015-06-09 Tx date 2015-06-05 |
$NPH
Vanc Pharmaceuticals Inc. |
NAYYAR, ARUN
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$275,000
+500,000 vol $0.55 each |
2,350,000 |